November 11, 2021 Comments Off on New patent for Gilead Sciences drug VEMLIDY Posted in: Patent Added Annual Drug Patent Expirations for VEMLIDY Vemlidy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are four…
The post New patent for Gilead Sciences drug VEMLIDY appeared first on DrugPaten…
November 11, 2021 Comments Off on New tentative approval for Radius Health drug abaloparatide Posted in: Tentative Approval Abaloparatide is the generic ingredient in one branded drug marketed by Radius Health Inc and is included in one NDA. There are four patents protecting this compound. This ingredient has…
The post New tentative approval for Radius Health drug abalopara…
